4 documents found, page 1 of 1
EULAR Points to Consider (PtC) for designing, analysing and reporting of studie...
Boonen, Annelies; Putrik, Polina; Marques, Mary Lucy; Alunno, Alessia; Abasolo, Lydia; Beaton, Dorcas; Betteridge, Neil; Bjørk, Mathilda; Boers, Maarten© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.; BACKGROUND: Clinical studies with work participation (WP) as an outcome domain pose particular methodological challenges that hamper interpretation, comparison between studies and meta-analyses. OBJECTIVES: To develop Points to Consider (PtC) for design, analysis and rep...
A reference case for economic evaluations in osteoarthritis
Hiligsmann, Mickaël; Cooper, Cyrus; Guillemin, Francis; Hochberg, Marc C.; Tugwell, Peter; Arden, Nigel; Berenbaum, Francis; Boers, MaartenPublisher Copyright: © 2014 The Authors.; Background: General recommendations for a reference case for economic studies in rheumatic diseases were published in 2002 in an initiative to improve the comparability of cost-effectiveness studies in the field. Since then, economic evaluations in osteoarthritis (OA) continue to show considerable heterogeneity in methodological approach. Objectives: To develop a refere...
An algorithm recommendation for the management of knee osteoarthritis in Europe...
Bruyère, Olivier; Cooper, Cyrus; Pelletier, Jean Pierre; Branco, Jaime; Luisa Brandi, Maria; Guillemin, Francis; Hochberg, Marc C.; Kanis, John A.Publisher Copyright: © 2014 The Authors.; Objectives: Existing practice guidelines for osteoarthritis (OA) analyze the evidence behind each proposed treatment but do not prioritize the interventions in a given sequence. The objective was to develop a treatment algorithm recommendation that is easier to interpret for the prescribing physician based on the available evidence and that is applicable in Europe and i...
Health economics in the field of osteoarthritis
Hiligsmann, Mickaël; Cooper, Cyrus; Arden, Nigel; Boers, Maarten; Branco, Jaime; Luisa Brandi, Maria; Bruyère, Olivier; Guillemin, FrancisFunding Information: M.H. (Mickael Hiligsmann) has received research grant, lecture fees, and/or consulting fees from Amgen, Pfizer, Novartis, Servier, and SMB. C.C. has received honoraria and consulting fees from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Medtronic, and Roche. M.-L.B. was consultant and grant recipient from Amgen, Eli Lilly, MSD, Novartis, NPS, Roch...